Partnership Research Program News Today

aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Achieve Milestones for First Year of Government Grant to Develop Bispecific Antibody Platform Two-year grant awarded by the Hong Kong Government’s Innovation and Technology Commission is funding the development of new bispecific antibodies targeting NRP2 May 12, 2021 08:00 ET | Source: aTyr Pharma, Inc. aTyr Pharma, Inc. San Diego, California, UNITED STATES SAN DIEGO, May 12, 2021 (GLOBE N...